Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation

Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of tumour-related death with late diagnoses and high recurrences. Circular RNA (circRNA) plays crucial roles in human malignancies. However, despite the potential as therapeutic target, the role of circRNA and their regulatory net...

Full description

Saved in:
Bibliographic Details
Main Authors: Ganlu Deng, Youwu He, Binliang Gan, Chuanjie Liao, Xinning Luo, Chunmei Zheng, Linfeng Mao
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06763-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334652090712064
author Ganlu Deng
Youwu He
Binliang Gan
Chuanjie Liao
Xinning Luo
Chunmei Zheng
Linfeng Mao
author_facet Ganlu Deng
Youwu He
Binliang Gan
Chuanjie Liao
Xinning Luo
Chunmei Zheng
Linfeng Mao
author_sort Ganlu Deng
collection DOAJ
description Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of tumour-related death with late diagnoses and high recurrences. Circular RNA (circRNA) plays crucial roles in human malignancies. However, despite the potential as therapeutic target, the role of circRNA and their regulatory network in hepatocellular carcinoma (HCC) remains unclear. Methods Comprehensive bioinformatics approaches were utilized to systematically identify differentially expressed circRNAs (DEcircRNAs) from multiple databases. The ceRNA regulatory network was constructed and the prognostic analysis was performed to screen out hub genes. Pan-cancer, bulk tissue RNA-sequences and single-cell sequences analysis were applied to explore the genetic characteristics and immune landscape of hub genes. By a series of functional assays, the effect of hub circRNA on HCC proliferation, migration and autophagy was assayed both in vitro and in vivo. Dual luciferase reporter and rescue assay were performed for the mechanistic study. Results A total of 36 DEcircRNAs were identified and 20 of them were predicted binding with miRNAs binding sites potentially. After establishing the ceRNA regulatory network, functional enrichment, PPI network and prognostic analysis, YWHAZ was discovered as a hub gene in HCC and the subnetwork of hsa_circ_0016662/hsa-miR-22-3p/YWHAZ was recognized. Pan-cancer analysis revealed that YWHAZ was overexpressed and correlated with poor prognosis in most cancers with a 15% frequency of genetic alterations. Multiomics analysis from bulk RNA-sequencing and single-cell RNA-sequencing showed that YWHAZ was a preferable diagnostic and prognostic biomarker in HCC. YWHAZ was associated with suppressive immune microenvironment via positively correlated with the enrichment of macrophages and Tregs, as well as the immunosuppression genes. Real-word cohort validated that hsa_circ_0016662 and YWHAZ were upregulated in HCC while hsa-miR-22-3p was downregulated. Knockdown of hsa_circ_0016662 suppressed HCC malignant progression both in vitro and in vivo. Autophagy participated in hsa_circ_0016662-regulated HCC progression via sponging with hsa-miR-22-3p. Conclusions Our study identified hsa_circ_0016662 as a novel prognostic biomarker of HCC, promoting HCC progression by sponging with hsa-miR-22-3p via autophagy regulation. Targeting hsa_circ_0016662 might be a potential therapeutic strategy for HCC.
format Article
id doaj-art-dfd5966b111c4a84822ace273d8579a2
institution Kabale University
issn 1479-5876
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-dfd5966b111c4a84822ace273d8579a22025-08-20T03:45:31ZengBMCJournal of Translational Medicine1479-58762025-07-0123112110.1186/s12967-025-06763-1Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulationGanlu Deng0Youwu He1Binliang Gan2Chuanjie Liao3Xinning Luo4Chunmei Zheng5Linfeng Mao6Department of Oncology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pharmacy, The First Affiliated Hospital of Guangxi Medical UniversityKey Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University, Ministry of EducationAbstract Background Hepatocellular carcinoma (HCC) is a leading cause of tumour-related death with late diagnoses and high recurrences. Circular RNA (circRNA) plays crucial roles in human malignancies. However, despite the potential as therapeutic target, the role of circRNA and their regulatory network in hepatocellular carcinoma (HCC) remains unclear. Methods Comprehensive bioinformatics approaches were utilized to systematically identify differentially expressed circRNAs (DEcircRNAs) from multiple databases. The ceRNA regulatory network was constructed and the prognostic analysis was performed to screen out hub genes. Pan-cancer, bulk tissue RNA-sequences and single-cell sequences analysis were applied to explore the genetic characteristics and immune landscape of hub genes. By a series of functional assays, the effect of hub circRNA on HCC proliferation, migration and autophagy was assayed both in vitro and in vivo. Dual luciferase reporter and rescue assay were performed for the mechanistic study. Results A total of 36 DEcircRNAs were identified and 20 of them were predicted binding with miRNAs binding sites potentially. After establishing the ceRNA regulatory network, functional enrichment, PPI network and prognostic analysis, YWHAZ was discovered as a hub gene in HCC and the subnetwork of hsa_circ_0016662/hsa-miR-22-3p/YWHAZ was recognized. Pan-cancer analysis revealed that YWHAZ was overexpressed and correlated with poor prognosis in most cancers with a 15% frequency of genetic alterations. Multiomics analysis from bulk RNA-sequencing and single-cell RNA-sequencing showed that YWHAZ was a preferable diagnostic and prognostic biomarker in HCC. YWHAZ was associated with suppressive immune microenvironment via positively correlated with the enrichment of macrophages and Tregs, as well as the immunosuppression genes. Real-word cohort validated that hsa_circ_0016662 and YWHAZ were upregulated in HCC while hsa-miR-22-3p was downregulated. Knockdown of hsa_circ_0016662 suppressed HCC malignant progression both in vitro and in vivo. Autophagy participated in hsa_circ_0016662-regulated HCC progression via sponging with hsa-miR-22-3p. Conclusions Our study identified hsa_circ_0016662 as a novel prognostic biomarker of HCC, promoting HCC progression by sponging with hsa-miR-22-3p via autophagy regulation. Targeting hsa_circ_0016662 might be a potential therapeutic strategy for HCC.https://doi.org/10.1186/s12967-025-06763-1Circular RNAHepatocellular carcinomaAutophagyBiomarkerPrognosis
spellingShingle Ganlu Deng
Youwu He
Binliang Gan
Chuanjie Liao
Xinning Luo
Chunmei Zheng
Linfeng Mao
Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
Journal of Translational Medicine
Circular RNA
Hepatocellular carcinoma
Autophagy
Biomarker
Prognosis
title Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
title_full Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
title_fullStr Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
title_full_unstemmed Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
title_short Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
title_sort hsa circ 0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
topic Circular RNA
Hepatocellular carcinoma
Autophagy
Biomarker
Prognosis
url https://doi.org/10.1186/s12967-025-06763-1
work_keys_str_mv AT ganludeng hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation
AT youwuhe hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation
AT binlianggan hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation
AT chuanjieliao hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation
AT xinningluo hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation
AT chunmeizheng hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation
AT linfengmao hsacirc0016662actsasaprognosticbiomarkerandpromotestheprogressionofhepatocellularcarcinomaviaautophagyregulation